EA201270544A1 - Композиции с отсроченным высвобождением - Google Patents

Композиции с отсроченным высвобождением

Info

Publication number
EA201270544A1
EA201270544A1 EA201270544A EA201270544A EA201270544A1 EA 201270544 A1 EA201270544 A1 EA 201270544A1 EA 201270544 A EA201270544 A EA 201270544A EA 201270544 A EA201270544 A EA 201270544A EA 201270544 A1 EA201270544 A1 EA 201270544A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
extended delivery
pharmaceutical compositions
coating
contain
Prior art date
Application number
EA201270544A
Other languages
English (en)
Russian (ru)
Inventor
Давид Исаак Сильвер
Джулия Храковски
Роэй Соломонович
Дафна Ариели
Original Assignee
Тева Фармасьютикал Индастриз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тева Фармасьютикал Индастриз Лтд. filed Critical Тева Фармасьютикал Индастриз Лтд.
Publication of EA201270544A1 publication Critical patent/EA201270544A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
EA201270544A 2009-10-13 2009-10-13 Композиции с отсроченным высвобождением EA201270544A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/060551 WO2011046546A1 (en) 2009-10-13 2009-10-13 Delayed release compositions

Publications (1)

Publication Number Publication Date
EA201270544A1 true EA201270544A1 (ru) 2012-09-28

Family

ID=41683056

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270544A EA201270544A1 (ru) 2009-10-13 2009-10-13 Композиции с отсроченным высвобождением

Country Status (4)

Country Link
EP (1) EP2488173A1 (de)
EA (1) EA201270544A1 (de)
IL (1) IL218947A0 (de)
WO (1) WO2011046546A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6284163B2 (ja) 2013-01-30 2018-02-28 デウン カンパニー,リミテッド 胃腸管内における傷の保護、止血、または癒着の防止のための医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) * 2003-01-20 2003-02-19 Novartis Ag Organic compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
JP2009526771A (ja) * 2006-02-13 2009-07-23 ノバルティス アクチエンゲゼルシャフト 高投与量のミコフェノール酸(mpa)
US9642808B2 (en) * 2007-08-13 2017-05-09 Panacea Biotech Limited Extended release compositions comprising mycophenolate sodium and processes thereof
AR068745A1 (es) * 2007-10-08 2009-12-02 Panacea Biotec Ltd Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos

Also Published As

Publication number Publication date
IL218947A0 (en) 2012-07-31
WO2011046546A1 (en) 2011-04-21
EP2488173A1 (de) 2012-08-22

Similar Documents

Publication Publication Date Title
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
EA201170227A1 (ru) Имидазолкарбоксамиды
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
MY181898A (en) Heterocyclic compounds and uses thereof
WO2012077120A3 (en) Natural formulations
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
EA200802008A1 (ru) Фармацевтические композиции
EA201100268A1 (ru) Вакцина
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
MX341200B (es) Composicion farmaceutica de disolucion rapida.
MX2013002422A (es) Sales de lorcaserina con acidos opticamente activos.
EA201270590A1 (ru) Ингибиторы акт
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
TW200942530A (en) Pyridine compounds
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
MX2013007230A (es) Sistemas de polimero.
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
EA201491517A1 (ru) N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения